![Tae-Ho Hwang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tae-Ho Hwang
Corporate Officer/Principal bei Pusan National University
Aktive Positionen von Tae-Ho Hwang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pusan National University | Corporate Officer/Principal | - | - |
Pusan National University Hospital
![]() Pusan National University Hospital Hospital/Nursing ManagementHealth Services Pusan National University Hospital operates as a university hospital. | Corporate Officer/Principal | - | - |
Karriereverlauf von Tae-Ho Hwang
Ehemalige bekannte Positionen von Tae-Ho Hwang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SillaJen Biotherapeutics, Inc.
![]() SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
Baylor College of Medicine | Corporate Officer/Principal | - | - |
Dong-A University | Corporate Officer/Principal | - | - |
SILLAJEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2003 | - |
Gründer | 23.03.2006 | - |
Ausbildung von Tae-Ho Hwang
Pusan National University | Doctorate Degree |
Statistik
International
Südkorea | 5 |
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SILLAJEN, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Pusan National University Hospital
![]() Pusan National University Hospital Hospital/Nursing ManagementHealth Services Pusan National University Hospital operates as a university hospital. | Health Services |
SillaJen Biotherapeutics, Inc.
![]() SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Tae-Ho Hwang
- Erfahrung